Systemic Delivery of an Adjuvant CXCR4–CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy

胶质瘤 佐剂 免疫疗法 纳米颗粒 趋化因子 CXCR4型 癌症研究 药物输送 纳米技术 材料科学 免疫系统 医学 免疫学
作者
Mahmoud S. Alghamri,Kaushik Banerjee,Anzar Mujeeb,Ava Mauser,Ayman Taher,Rohit Thalla,Brandon L. McClellan,María L. Varela,Svetlana M. Stamatovic,Gabriela Martínez-Revollar,Anuska V. Andjelkovic,Jason V. Gregory,Padma Kadiyala,Anda‐Alexandra Calinescu,Jennifer A. Jiménez,April A. Apfelbaum,Elizabeth R. Lawlor,Stephen V. Carney,Andrea Comba,Syed Mohd Faisal
出处
期刊:ACS Nano [American Chemical Society]
卷期号:16 (6): 8729-8750 被引量:142
标识
DOI:10.1021/acsnano.1c07492
摘要

Glioblastoma (GBM) is an aggressive primary brain cancer, with a 5 year survival of ∼5%. Challenges that hamper GBM therapeutic efficacy include (i) tumor heterogeneity, (ii) treatment resistance, (iii) immunosuppressive tumor microenvironment (TME), and (iv) the blood–brain barrier (BBB). The C-X-C motif chemokine ligand-12/C-X-C motif chemokine receptor-4 (CXCL12/CXCR4) signaling pathway is activated in GBM and is associated with tumor progression. Although the CXCR4 antagonist (AMD3100) has been proposed as an attractive anti-GBM therapeutic target, it has poor pharmacokinetic properties, and unfavorable bioavailability has hampered its clinical implementation. Thus, we developed synthetic protein nanoparticles (SPNPs) coated with the transcytotic peptide iRGD (AMD3100-SPNPs) to target the CXCL2/CXCR4 pathway in GBM via systemic delivery. We showed that AMD3100-SPNPs block CXCL12/CXCR4 signaling in three mouse and human GBM cell cultures in vitro and in a GBM mouse model in vivo. This results in (i) inhibition of GBM proliferation, (ii) reduced infiltration of CXCR4+ monocytic myeloid-derived suppressor cells (M-MDSCs) into the TME, (iii) restoration of BBB integrity, and (iv) induction of immunogenic cell death (ICD), sensitizing the tumor to radiotherapy and leading to anti-GBM immunity. Additionally, we showed that combining AMD3100-SPNPs with radiation led to long-term survival, with ∼60% of GBM tumor-bearing mice remaining tumor free after rechallenging with a second GBM in the contralateral hemisphere. This was due to a sustained anti-GBM immunological memory response that prevented tumor recurrence without additional treatment. In view of the potent ICD induction and reprogrammed tumor microenvironment, this SPNP-mediated strategy has a significant clinical translation applicability.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
平生发布了新的文献求助50
1秒前
YiRan发布了新的文献求助10
1秒前
追寻惜萱完成签到 ,获得积分10
1秒前
WhaleHu完成签到,获得积分10
1秒前
李健的应助被电生理搬运工采纳,获得10
2秒前
kyscro发布了新的文献求助10
2秒前
单薄冰安发布了新的文献求助10
2秒前
可爱的函函的应助被之之采纳,获得10
2秒前
祓木完成签到,获得积分10
3秒前
3秒前
4秒前
元元关注了科研通微信公众号
5秒前
6秒前
飞翔完成签到,获得积分10
6秒前
斯文败类的应助被啵子采纳,获得10
6秒前
6秒前
小二郎的应助被踏实凡桃采纳,获得10
7秒前
7秒前
111发布了新的文献求助10
7秒前
Hello的应助被conniechen采纳,获得10
7秒前
xx发布了新的文献求助10
8秒前
华仔的应助被开心德地采纳,获得10
8秒前
小马甲的应助被wg采纳,获得10
9秒前
KK完成签到,获得积分10
9秒前
10秒前
君澔发布了新的文献求助10
11秒前
我是谁完成签到,获得积分20
12秒前
沐沐发布了新的文献求助10
12秒前
小杨完成签到,获得积分10
12秒前
合法的天空完成签到,获得积分10
13秒前
13秒前
Zz发布了新的文献求助200
13秒前
大胆的马里奥完成签到,获得积分10
14秒前
水煮电吹风的应助被萧笙采纳,获得10
15秒前
橙巧巧和乌霉霉完成签到,获得积分10
17秒前
18秒前
18秒前
19秒前
甘甚么完成签到,获得积分10
20秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188654
求助须知:如何正确求助?哪些是违规求助? 9576372
关于积分的说明 21847161
捐赠科研通 7786741
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360